Vestibular Dysfunction and Glucose Metabolism
Fractionated and Restrictive Glucose Diet in Patients With Vestibular Dysfunction: a Randomized Controlled Trial
1 other identifier
interventional
51
0 countries
N/A
Brief Summary
Introduction: the global sugar consumption has increased in the past 50 years and their abusive intake is responsible for the insulin resistance and causes the metabolic syndrome - obesity, diabetes mellitus, hypertension and coronary heart disease. Objective: To evaluate the effect of scheduled diet without glucose as treatment of labyrinthine disorders associated with glucose-insulin index. Study Design: A prospective randomized controlled trial. Patients and Methods: A study conducted at the University of São Paulo with 51 patients divided into two groups: Diet Group (DG) that comprises subjects treated with fractionated diet with glucose restriction and control group (CG) where individuals were not counseled regarding diet. Patients underwent computerized dynamic posturography - sensory organization test (CDP - SOT) and Visual Analog Scale (VAS) in the first and thirtieth days of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2005
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 6, 2014
CompletedFirst Posted
Study publicly available on registry
August 27, 2014
CompletedJune 14, 2022
June 1, 2022
5 years
August 6, 2014
June 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of equilibrium score through the computerized dynamic posturography (CDP) in 51 patients
30 days
Secondary Outcomes (1)
Self perception of dizziness mesured by the visual analogue scale
30 days
Study Arms (2)
control
PLACEBO COMPARATORUsual diet without any orientation
fractioned diet without glucose
ACTIVE COMPARATORFractioned diet without glucose
Interventions
Patients were divided into two groups: Diet Group was treated with placebo pills and glucose restrictive and fractionated diet. Control Group received only placebo pills. All individuals had their vestibular function evaluated by Computerized Dynamic Posturography and done visual analogue scale (VAS) in the first day and 30 days after diet intervention
Eligibility Criteria
You may qualify if:
- dizziness related to fasting or glucose intake
- alterations of glucose tolerance test
You may not qualify if:
- dizziness not related to vestibular problems
- ortopedical or neurological diseases
- diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roseli SM Bittar, MD, PhD
University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistente Doutor da Faculdade de Medicina da Universidade de São Paulo
Study Record Dates
First Submitted
August 6, 2014
First Posted
August 27, 2014
Study Start
December 1, 2005
Primary Completion
December 1, 2010
Study Completion
December 1, 2011
Last Updated
June 14, 2022
Record last verified: 2022-06